For instance, widespread vitamin D deficiency (25(OH)D <20 μg/L in 68% of T2D patients) may independently suppress osteoblast activity and amplify PTH secretion - potentially obscuring TyG-BMI’s true relationship with bone formation markers like TP1NP and osteocalcin. The gene discussed is BGLAP; the disease is vitamin D deficiency.